Insights

Global market potential MiStent SES is CE-marked and sold internationally through distribution partners, with Europe receptivity via STENTYS, indicating strong international sales opportunities and potential for expanded distribution partnerships in other regions.

Growth through financing Micell has a history of funding activity including a $6M private offering and an overall funding of $90M, signaling investor confidence and potential for capital-backed scaling, clinical trials, or partner-led growth initiatives.

Strategic acquisition Acquisition by Kossel Medical in late 2021 and subsequent global strategy emphasis suggest corporate-backed expansion momentum and potential collaboration on regulatory approvals, distribution, and co-developed products.

Regulatory niche Current US market access is limited to not yet approved status for MiStent SES, creating a clear sales focus on Europe and other regions while identifying near-term US partnerships or licensing opportunities to accelerate market entry.

Technology differentiator Unique supercritical fluid technology for drug-eluting devices positions Micell to target cardiovascular disease applications and unmet needs in drug-delivery performance, presenting a differentiated value proposition for hospital networks, distributors, and device OEMs seeking innovation.

Similar companies to Micell Technologies, Inc.

Micell Technologies, Inc. Tech Stack

Micell Technologies, Inc. uses 8 technology products and services including RSS, WordPress, MySQL, and more. Explore Micell Technologies, Inc.'s tech stack below.

  • RSS
    Content Management System
  • Content Management System
  • MySQL
    Database
  • Network Solutions
    Domain Name Services
  • jQuery
    Javascript Libraries
  • Cloudways
    Platform As A Service
  • Nginx
    Web Servers

Micell Technologies, Inc.'s Email Address Formats

Micell Technologies, Inc. uses at least 2 email formats:
Micell Technologies, Inc. Email FormatsExamplePercentage
FLast@micell.comJDoe@micell.com
96%
First.Last@micell.comJohn.Doe@micell.com
4%

Frequently Asked Questions

What is Micell Technologies, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Micell Technologies, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Micell Technologies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Micell Technologies, Inc.'s official website is micell.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Micell Technologies, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Micell Technologies, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Micell Technologies, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Micell Technologies, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Micell Technologies, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Micell Technologies, Inc. has approximately 10 employees across 2 continents, including North America and South America. Key team members include Accounting Administrator: P. S. Explore Micell Technologies, Inc.'s employee directory with LeadIQ.

What industry does Micell Technologies, Inc. belong to?

Minus sign iconPlus sign icon
Micell Technologies, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does Micell Technologies, Inc. use?

Minus sign iconPlus sign icon
Micell Technologies, Inc.'s tech stack includes RSS, WordPress, MySQL, Network Solutions, jQuery, Cloudways, DigitalOcean Web Hosting and Nginx.

What is Micell Technologies, Inc.'s email format?

Minus sign iconPlus sign icon
Micell Technologies, Inc.'s email format typically follows the pattern of FLast@micell.com. Find more Micell Technologies, Inc. email formats with LeadIQ.

How much funding has Micell Technologies, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Micell Technologies, Inc. has raised $90M in funding. The last funding round occurred on Sep 19, 2017 for $62M.
Micell Technologies, Inc. logo

Micell Technologies, Inc.

Medical Equipment ManufacturingUnited States2-10 Employees

Micell Technologies, Inc. is a small United States-based medical device company focused on improving drug delivery within interventional cardiology. Its approach centers on a supercritical fluid technology designed to overcome limitations of conventional drug-eluting devices and improve outcomes for patients undergoing cardiovascular procedures.

The flagship MiStent SES is a CE-marked drug-eluting stent sold in many countries and distributed in Europe through STENTYS, with no approval for use in the United States. The firm is based in Durham and operates with a compact team. In December 2021, Micell Technologies was acquired by Kossel Medical as part of its global strategy.

Section iconCompany Overview

Phone number
Website
micell.com
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $90M

    Micell Technologies, Inc. has raised a total of $90M of funding over 6 rounds. Their latest funding round was raised on Sep 19, 2017 in the amount of $62M as a Venture Round.

  • $1M - $10M

    Micell Technologies, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.